Growing community of inventors

Seoul, South Korea

Gi Hoon Son

Average Co-Inventor Count = 3.82

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Gi Hoon SonDong-Hoon Kim (2 patents)Gi Hoon SonJae Young Seong (2 patents)Gi Hoon SonJong-Ik Hwang (2 patents)Gi Hoon SonYoo-Na Lee (2 patents)Gi Hoon SonSeongsik Yun (2 patents)Gi Hoon SonArfaxad Reyes-Alcaraz (2 patents)Gi Hoon SonJong Hwa Jung (1 patent)Gi Hoon SonDong-Hoon Kim (1 patent)Gi Hoon SonGi Hoon Son (3 patents)Dong-Hoon KimDong-Hoon Kim (42 patents)Jae Young SeongJae Young Seong (10 patents)Jong-Ik HwangJong-Ik Hwang (3 patents)Yoo-Na LeeYoo-Na Lee (2 patents)Seongsik YunSeongsik Yun (2 patents)Arfaxad Reyes-AlcarazArfaxad Reyes-Alcaraz (2 patents)Jong Hwa JungJong Hwa Jung (2 patents)Dong-Hoon KimDong-Hoon Kim (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Neuracle Science Co., Ltd. (2 from 18 patents)

2. Korea University Research and Business Foundation (1 from 1,142 patents)

3. Kyungpook National University Industry-Academic Cooperation Foundation (1 from 336 patents)


3 patents:

1. 12246002 - Pharmaceutical composition for prevention or treatment of circadian rhythm-related disorders, comprising oxyiminomethylbenzene derivative as active ingredient

2. 11248023 - Agonist of spexin-based galanin type 2 receptor and use thereof

3. 10385098 - Agonist of spexin-based galanin type 2 receptor and use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…